FDA Approves New HIV Drug Edurant

The FDA has approved Edurant (rilpivirine) for use in anti-HIV drug cocktails. Edurant is as effective as the popular Sustiva and is in the same NNRTI class of antiretroviral drugs.

Click here to read the full story.

Post a Comment
 

Enter the words shown above Enter the numbers you hear
Refresh Image Audio Help
 
Comments
No comments yet!

The Health News section does not provide medical advice, diagnosis or treatment. See additional information.

Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.